HIV controllers: How these patients control viral replication?;Les patients HIV controllers

Medecine/Sciences

Volumn 28, Issue 2, 2012, Pages 172-178

  Lambotte, Olivier ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE COUNT; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS REPLICATION;

HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE COUNT; MODELS, BIOLOGICAL; VIRUS REPLICATION;

EID: 84858196162     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20122S2015     Document Type: Review

References (42)

1. Barker E, Mackewicz CE, Reyes-Teran G, et al. Virological and immunological features of longterm human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998 ; 92: 3105-14. (Pubitemid 28492316)
2. Cao y, Qin L, Zhang L, et al. Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995 ; 332 : 201-8.
3. Martinez V. Combination of HIV-l-specific CD4 Thl cell responses and lgG2 antibodies is the best predictor for persistence of long-term nonprogression.; Infect Dis 2005 ; 191 : 2053-63. (Pubitemid 40800576)
4. Lefrere JJ, Morand-Joubert L, Mariotti M, et al. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 1997 ; 90: 1133-40. (Pubitemid 27314149)
5. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers: a homogeneous group of HIV-l-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005 ; 41 : 1053-6. (Pubitemid 41368233)
6. Okulicz JF, Marconi VC, Landrum ML, et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis 2009 ; 200: 1714-23.
7. Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l'infection par le VIH ? Med Sci (Paris) 2008 ; 24 : 7-9. (Pubitemid 351195635)
8. Grabar S, Selinger-Leneman H, Abgrall S, et al. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. Aids 2009; 23:1163-9.
9. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.; Infect Dis 2008 ; 197 : 563-71. (Pubitemid 351321534)
10. Boufassa F, Saez-Cirion A, Lechenadec J, et al. CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory. PloS One 2011 ; 6 : el8726.
11. Pereyra F, Palmer S, Mrura T, et al. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J. Infect Dis 2009 ; 200:984-90.
12. Lamine A, Caumont-Sarcos A, Chaix ML, et al. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study).Aids 2007 ; 21:1043-5. (Pubitemid 46684337)
13. Miura T, Brockman MA, Brumme CJ, et al. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.; Virol 2008 ; 82 : 8422-30.
14. Hatano H, Delwart EL, Norris PJ, et al. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antirétroviral therapy. J Virol 2009 ; 83 : 329-35.
15. Miura T, Brockman MA, Brumme ZL, et al. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.J Virol 2009 ; 83:140-9.
16. Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS 2011 ; 6:163-8.
17. Dalmasso C, Carpentier W, Meyer L, et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome wide association 01 study. PloS One 2008 ; 3 : e3907.
18. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007 ; 317 : 944-7. (Pubitemid 47301321)
19. · T cells during HIV infection. Nat Med 2008 ; 14 : 266-74. (Pubitemid 351347916)
20. Vigneault F, Woods M, Buzon MJ, et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.;J Virol 2011 ; 85 : 3015-9.
21. Saez-Cirion A, Hamimi C, Bergamaschi A, etal. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 2011; 118 : 955-64.
22. · T cells from elite controllers resist HIV-1 infection by selective upregulation of p21J Clin Invest 2011 ; 121 : 1549-60.
23. Brenchley JM, Price DA, Schacker TV/, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006 ; 12 : 1365-71. (Pubitemid 44924494)
24. Hunt PW, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+ T cell count in HlV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.; Infect Dis 2008 ; 197 : 126-33. (Pubitemid 351263476)
25. Hsue Py, Hunt PW, Sinclair E, et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirusspecific T-cell responses. Aids 2006 ; 20: 2275-83. (Pubitemid 44789529)
26. Saez-Cirion A, Lacabaratz C, Lambotte 0, et al. HIV controllers exhibit potent CDS T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007 ; 104:6776-81. (Pubitemid 47175577)
27. Saez-Cirion A, Pancino G, Sinet M, et al. HIV controllers: how do they tame the virus? Trends Immunol 2007 ; 28 : 532-40.
28. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8' T cells. Blood 2006 ; 107 : 4781-9. (Pubitemid 43882629)
29. Hersperger AR, Pereyra F, Nason M, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLaS Pathog 2010 ; 6 : el000917.
30. · T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002 ; 3 :1061-8. (Pubitemid 35363659)
31. Saez-Cirion A, Sinet M, Shin Sy, et al. Heterogeneity in HIV suppression by CDS T cells from HIV controllers: association with Gag-specific CDS T cell responses.; Immunol 2009 ; 182 : 7828-37.
32. Miura T, Brockman MA, Schneidewind A, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte (corrected) recognition.; Viral 2009 ; 83: 2743-55.
33. · T-cell subsets in human immunodeficiency virus controllers: an ANRS 6P36 study. J Virol 2007; 81:13904-15. (Pubitemid 350247883)
34. Vingert B, Perez-Patrigeon S, Jeannin P, et al. HIV controller CD4' T cells respond to minimal amounts of Gag antigen due to high TCR avidity PloS Pathog 2011 ; 6 : el000780.
35. O'Connell KA, Han y, Williams TM, et al. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J Virol 2009 ; 83 : 5028-34.
36. Vieillard V, Fausther-Bovendo H, Samri A, Debre P. Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers.J Acquir Immune Defic Syndr 2011 ; 53: 564-73.
37. Lambotte 0, Ferrari G, Moog C, et al. Heterogeneous neutralizing antibody and antibodydependent cell cytotoxicity responses in HIV-1 elite controllers. Aids 2009 ; 23 : 897-906.
38. Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antirétroviral treatment.; Virol 2005 ; 79 :14169-78. (Pubitemid 41552715)
39. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001 ;410:980-7. (Pubitemid 32335849)
40. Goujard C, Chaix ML, Lambotte 0, et al. Spontaneous control of viral replication during primary HIV infection: when is "IV controller" status established? Clin Infect Dis 2009 ; 49:982-6.
41. Ferre AL, Hunt PW, Critchfield JW, et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009 ; 113 :3978-89.
42. Cellerai C, Haran A, Stauss H, et al. Early and prolonged antirétroviral therapy is associated with an HIV-l-specific T-cell profile comparable to that of long-term non-progressors. PLoSOne 2011 ; 6 : e18164.